30 Jun, 2021 RNAi Roundtable: Zilebesiran (ALN-AGT), in Development for the Treatment of Hypertension
Posted at 10:16h
in Capella
On June 30, 2021, we hosted an online RNAi Roundtable to review the progress with zilebesiran (ALN-AGT), an RNAi therapeutic in development for the treatment of hypertension.
Access the replay
View the presentation
Pushkal Garg, M.D.
Chief Medical Officer
Elizabeth Ofili, M.D., MPH, FACC
Professor of Medicine (Cardiology), Morehouse School of Medicine
Stephen Huang, M.D.
Senior Director, Clinical Research
Eric Green
Senior Vice President, Development Programs
